Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 23, 2025 10:16 ET | Source: Pixalate

Pixalate Releases Global Top 25 Most Popular Connected TV (CTV) Virtual Multichannel Video Programming Distribution (vMVPD) Apps Reports for Q3 2025: ‘Plex’ No. 1 on Apple TV, Tubi Leads on Roku

The list ranks the top 25 most popular vMVPD Bundle IDs based on global open programmatic advertising volume across CTV platforms.
October 20, 2025 14:02 ET | Source: Cayman Enterprise City

Cayman Enterprise City Secures #6 Spot in Prestigious Global Free Zone Rankings

Cayman Enterprise City earns triple honours from Financial Times’ fDi Intelligence: Ranked #6 globally, named Knowledge Zone of the Year in the Americas.
October 20, 2025 08:00 ET | Source: Bakkt, LLC

Bakkt Strengthens Board with Appointment of Renowned Macro Strategist Lyn Alden

NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Bakkt Holdings, Inc. (“Bakkt” or the “Company”) (NYSE: BKKT) today announced the appointment of Lyn Alden to its Board of Directors. Lyn is an investor,...
October 20, 2025 07:41 ET | Source: Clearmind Medicine Inc.

Clearmind Medicine Announces Publication of U.S. Patent Application Targeting Binge Behavior Disorders

Vancouver, Canada, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and...
October 14, 2025 08:00 ET | Source: CYTOMED THERAPEUTICS LIMITED

CytoMed makes cash bid for potential acquisition of TC BioPharm Limited’s relevant assets

SINGAPORE, Oct. 14, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing...
October 08, 2025 07:09 ET | Source: Nilo Therapeutics

Nilo Therapeutics launches with $101 million Series A financing to advance a new class of medicines targeting neural circuits in immune disease and appoints Kim Seth as Chief Executive Officer

Nilo Therapeutics launches with $101 million Series A to target neural circuits in immune disease and appoints Kim Seth as Chief Executive Officer
October 07, 2025 10:30 ET | Source: Precedence Research

Digital Therapeutics Market Size to Lead USD 56.76 Bn by 2034 Driven by Digital Therapeutics, Cost Control, and Chronic Disease Prevalence

Ottawa, Oct. 07, 2025 (GLOBE NEWSWIRE) -- According to Statifacts, the global digital therapeutics market size reached USD 7.88 billion in 2024 and is estimated to attain USD 56.76 billion by 2034,...
September 29, 2025 08:15 ET | Source: Royalty Pharma plc

Royalty Pharma Appoints Dr. Ted W. Love As Lead Independent Director

NEW YORK, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that the independent directors of the Board have unanimously appointed Dr. Ted W. Love, an independent...
September 24, 2025 08:30 ET | Source: Holley Performance Brands

Simpson Motorcycle Accelerates Global Growth Strategy in $7B Motorcycle Safety Market

BOWLING GREEN, Ky., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Holley Performance Brands (NYSE: HLLY), a leader in automotive aftermarket performance solutions, today announced strategic momentum in its...
September 23, 2025 08:01 ET | Source: Liberty Defense

Liberty Defense Completes Significant Milestone for High-Definition Advanced Imaging Technology Kit (HD-AIT)

WILMINGTON, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Liberty Defense Holdings Ltd. (“Liberty” or the “Company”) (TSXV: SCAN, OTCQB: LDDFF, FSE:E30), a leading technology provider of AI-based next...